Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2025-12-25 @ 7:10 PM
Study NCT ID:
NCT04389632
Status:
RECRUITING
Last Update Posted:
2025-12-09
First Post:
2020-05-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Sponsor:
Seagen, a wholly owned subsidiary of Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-08
Start Date Type:
ACTUAL
Primary Completion Date:
2027-06-16
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-03-22
Completion Date Type:
ESTIMATED
First Submit Date:
2020-05-12
First Submit QC Date:
None
Study First Post Date:
2020-05-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-08
Last Update Post Date:
2025-12-09
Last Update Post Date Type:
ESTIMATED